Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.48 USD | -4.40% | -9.14% | -15.94% |
May. 08 | Transcript : Relmada Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
May. 08 | Relmada Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.94% | 105M | |
+7.52% | 113B | |
+11.38% | 106B | |
+0.84% | 22.27B | |
-12.64% | 22.22B | |
-4.22% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+7.77% | 14.29B | |
+37.41% | 12.52B |
- Stock Market
- Equities
- RLMD Stock
- News Relmada Therapeutics, Inc.
- Relmada Therapeutics Says Drug Candidate for Major Depressive Disorder Gets FDA Fast-Track Designation